NVNO Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
3.8M
-6.5%
4.1M
+1.2%
4.0M
-17.8%
4.9M
-30.7%
7.0M
R&D
2.1M
-1.7%
2.1M
+8.4%
1.9M
-24.6%
2.6M
-10.6%
2.9M
SG&A
1.7M
-11.8%
2.0M
-5.5%
2.1M
-10.1%
2.3M
-44.7%
4.2M
Operating Income
-3796000
+6.5%
-4062000
-1.2%
-4013000
+17.8%
-4883000
+30.7%
-7049000
EBITDA
-3859000
+4.3%
-4031000
-1.2%
-3982000
+17.9%
-4852000
+30.8%
-7015000
Net Income
-3600000
+6.5%
-3849000
-3.0%
-3736000
+17.7%
-4539000
+32.2%
-6694000
EPS (Basic)
$-5.37
+8.8%
$-5.89
$-8.05
+30.1%
$-11.52
EPS (Diluted)
$-5.37
+8.8%
$-5.89
$-8.05
+30.1%
$-11.52
Shares (Diluted)
671.0K
+2.6%
654.0K
575.9K
-0.9%
581.0K
enVVeno Medical (NVNO) — Financials